(Q53956207)

22 May 2018

title

High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. (English)

1 reference

22 May 2018

multicenter clinical trial

main subject

1 reference

1 reference

Krutmann J

1

1 reference

22 May 2018

Diepgen TL

2

1 reference

22 May 2018

Luger TA

3

1 reference

22 May 2018

Grabbe S

4

1 reference

22 May 2018

Meffert H

5

1 reference

22 May 2018

Sönnichsen N

6

1 reference

22 May 2018

Czech W

7

1 reference

22 May 2018

Kapp A

8

1 reference

22 May 2018

Stege H

9

1 reference

22 May 2018

Grewe M

10

1 reference

22 May 2018

Schöpf E

11

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

22 May 2018

Journal of the American Academy of Dermatology

published in

1 reference

22 May 2018

volume

38

1 reference

22 May 2018

issue

4

1 reference

22 May 2018

page(s)

589-593

1 reference

22 May 2018

Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

High-dose UVA1 therapy in the treatment of patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

Eosinophil cationic protein in sera of patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

Recombinant interferon gamma therapy for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

IgE on Langerhans cells: new insights into the pathogenesis of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

Fc epsilon RI on human Langerhans cells: a receptor in search of new functions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

Immunoglobulin E-binding structures on antigen-presenting cells present in skin and blood

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

High-dose UVA1 for urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

Lesional expression of interferon-gamma in atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970123-9

7 January 2021

10.1016/S0190-9622(98)70123-9

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

9555799

1 reference

22 May 2018